Immuron (IMRN) Other financing activities (2019 - 2021)
Immuron (IMRN) recorded quarterly Other financing activities of -$2.0 million in Q4 2021, up 26.8% quarter-over-quarter from -$2.7 million in Q4 2020, and up 26.8% on a YoY basis from -$1.6 million in Q4 2020.
Immuron (IMRN) Other financing activities (2019 - 2021) Analysis & Trends
Immuron's Other financing activities history runs 3 years deep, the most recent figure standing at -$2.0 million for Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Immuron | 1.05 Bn | 1.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -2.01 Mn |
| Dec 31, 2021 | -2.01 Mn |
| Dec 31, 2020 | -2.75 Mn |
| Dec 31, 2020 | -2.75 Mn |
| Dec 31, 2019 | -374,728.00 |
| Dec 31, 2019 | -374,728.00 |